Boston Scientific earnings were $3.5B for the trailing 12 months ending Sep 30, 2026, with 25.9% growth year over year. The latest BSX earnings report on Sep 30, 2026 announced Q3 2026 earnings of $582.0M, down 35.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BSX reported annual earnings of $2.9B, with 56.4% growth.
BSX past earnings growth
How has BSX's earnings growth performed historically?
What were Boston Scientific's earnings last quarter?
On BSX's earnings call on Oct 28, 2026, Boston Scientific (NYSE: BSX) reported Q3 2026 earnings per share (EPS) of $0.40, up 21.57% year over year. Total BSX earnings for the quarter were $582.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.51.
As of the last Boston Scientific earnings report, Boston Scientific is currently profitable. Boston Scientific's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $3.50 billion, a 25.43% increase year over year.
What was BSX's earnings growth in the past year?
As of Boston Scientific's earnings date in Oct 28, 2026, Boston Scientific's earnings has grown 25.93% year over year. This is 33.55 percentage points higher than the US Medical Devices industry earnings growth rate of -7.62%. BSX earnings in the past year totalled $3.50 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.